1,3-Benzodioxolyl-N-ethylpentanamine

EBDP
Clinical data
Other namesN-Ethyl-1,3-benzodioxolylpentanamine; 1,3-Benzodioxolyl-N-ethylpentanamine; EBDP; 3,4-Methylenedioxy-α-propyl-N-ethylphenethylamine
Routes of
administration		Oral[1]
ATC code
  • None
Pharmacokinetic data
Duration of actionUnknown[1]
Identifiers
  • 1-(2H-1,3-benzodioxol-5-yl)-N-ethylpentan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H21NO2
Molar mass235.327 g·mol−1
3D model (JSmol)
  • C1=C2C(=CC=C1CC(CCC)NCC)OCO2
  • InChI=1S/C14H21NO2/c1-3-5-12(15-4-2)8-11-6-7-13-14(9-11)17-10-16-13/h6-7,9,12,15H,3-5,8,10H2,1-2H3
  • Key:YIJZJPAWMJJXQD-UHFFFAOYSA-N

EBDP, also known as N-ethyl-1,3-benzodioxolylpentanamine, 3,4-methylenedioxy-N-ethyl-α-propylphenethylamine, or ethyl-K, is a psychoactive drug of the phenethylamine, amphetamine, and MDxx families.[1] It is the N-ethyl analogue of BDP (K).[1]

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists EBDP's dose as greater than 40 mg orally and its duration as unknown.[1] It produced a paresthetic twinge in the shoulder and no other effects at tested doses.[1]

Chemistry

Synthesis

The chemical synthesis of EBDP has been described.[1]

Society and culture

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]

See also

References

  1. ^ a b c d e f g Ethyl-K entry in PiHKAL • info
  2. ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.
allikas: https://en.wikipedia.org/wiki/1,3-benzodioxolyl-N-ethylpentanamine